Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tom Walley

Showing results (11-20 of 54) with videos related to

Pageof 6
Sort By:
BMJ (Clinical Research Ed.)|April 16, 2005
Direct to consumer marketing: switch to over the counter can become indirect advertising directly to consumersMartin Duerden, Tom Walley
BMJ (Clinical Research Ed.)|February 14, 2006
Diagnostics is not Cinderella of health technology assessmentJohn Gabbay, Tom Walley
Family Practice|September 26, 2003
New drug uptake: qualitative comparison of high and low prescribing GPs' attitudes and approachHelen Prosser, Tom Walley
International Journal of Technology Assessment in Health Care|May 13, 2022
Assessing the value of healthcare innovations: a proposal for an integrated health technology assessment-responsible innovation in health approach in the "new normal"Kanchan Mukherjee, Tom Walley
Social Science & Medicine (1982)|January 1, 2005
A qualitative study of GPs' and PCO stakeholders' views on the importance and influence of cost on prescribingHelen Prosser, Tom Walley
Social Science & Medicine (1982)|October 4, 2005
New drug prescribing by hospital doctors: the nature and meaning of knowledgeHelen Prosser, Tom Walley
Journal of Health Organization and Management|April 26, 2007
Perceptions of the impact of primary care organizations on GP prescribing: the iron fist in the velvet glove?Helen Prosser, Tom Walley
Pharmacoeconomics|September 14, 2010
Using comparative effectiveness research to inform policy and practice in the UK HHS: past, present and futureKalipso Chalkidou, Tom Walley
BMJ (Clinical Research Ed.)|January 18, 2006
Introducing new health interventionsJohn Gabbay, Tom Walley
The British Journal of General Practice : the Journal of the Royal College of General Practitioners|July 26, 2003
Understanding why GPs see pharmaceutical representatives: a qualitative interview studyHelen Prosser, Tom Walley
Pageof 6

Showing results (11-20 of 54) with videos related to

Sort By:
Pageof 6
BMJ (Clinical Research Ed.)|April 16, 2005
Direct to consumer marketing: switch to over the counter can become indirect advertising directly to consumersMartin Duerden, Tom Walley
BMJ (Clinical Research Ed.)|February 14, 2006
Diagnostics is not Cinderella of health technology assessmentJohn Gabbay, Tom Walley
Family Practice|September 26, 2003
New drug uptake: qualitative comparison of high and low prescribing GPs' attitudes and approachHelen Prosser, Tom Walley
International Journal of Technology Assessment in Health Care|May 13, 2022
Assessing the value of healthcare innovations: a proposal for an integrated health technology assessment-responsible innovation in health approach in the "new normal"Kanchan Mukherjee, Tom Walley
Social Science & Medicine (1982)|January 1, 2005
A qualitative study of GPs' and PCO stakeholders' views on the importance and influence of cost on prescribingHelen Prosser, Tom Walley
Social Science & Medicine (1982)|October 4, 2005
New drug prescribing by hospital doctors: the nature and meaning of knowledgeHelen Prosser, Tom Walley
Journal of Health Organization and Management|April 26, 2007
Perceptions of the impact of primary care organizations on GP prescribing: the iron fist in the velvet glove?Helen Prosser, Tom Walley
Pharmacoeconomics|September 14, 2010
Using comparative effectiveness research to inform policy and practice in the UK HHS: past, present and futureKalipso Chalkidou, Tom Walley
BMJ (Clinical Research Ed.)|January 18, 2006
Introducing new health interventionsJohn Gabbay, Tom Walley
The British Journal of General Practice : the Journal of the Royal College of General Practitioners|July 26, 2003
Understanding why GPs see pharmaceutical representatives: a qualitative interview studyHelen Prosser, Tom Walley
Pageof 6